Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta-analysis

Background and objective Brivudine has been used in herpes zoster (HZ) treatment for years, but the safety and efficacy of brivudine are inconclusive. Here we perform a meta-analysis to assess the efficacy, safety, incidence of postherpetic neuralgia of brivudine.Methods Data of randomized controlle...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiaxing Chen, Dongyun Lei, Peng Cao, Junchen He, Litao Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2024.2355256
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846119650181513216
author Jiaxing Chen
Dongyun Lei
Peng Cao
Junchen He
Litao Zhang
author_facet Jiaxing Chen
Dongyun Lei
Peng Cao
Junchen He
Litao Zhang
author_sort Jiaxing Chen
collection DOAJ
description Background and objective Brivudine has been used in herpes zoster (HZ) treatment for years, but the safety and efficacy of brivudine are inconclusive. Here we perform a meta-analysis to assess the efficacy, safety, incidence of postherpetic neuralgia of brivudine.Methods Data of randomized controlled Trials (RCTS) were obtained from the databases of both English (PubMed, Embase, and Cochrane Library) and Chinese (China National Knowledge Infrastructure, China Science Journal Database, and WanFang Database) literatures from inception to 12 September 2022. Meta-analyses of efficacy and safety of Brivudine for the treatment of herpes zoster for RCTS were conducted.Results The analyses included seven RCTS (2095 patients in experimental group and 2076 patients in control group) in the treatment of HZ with brivudine. It suggested that the brivudine group was superior to the control group in terms of efficacy (p = .0002) and incidence of postherpetic neuralgia (p = .04). But the incidence of adverse reactions has no significant difference between the brivudine and the control groups (p = .22). In addition, subgroup analysis of adverse events also showed that brivudine was about the same safety as other modalities in the treatment of HZ (p > .05).Conclusions Brivudine is effective for HZ. However, the evidence on the safety of brivudine is insufficient.
format Article
id doaj-art-c5b3cc7d338d44f4a0d1db02850413c3
institution Kabale University
issn 0954-6634
1471-1753
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Dermatological Treatment
spelling doaj-art-c5b3cc7d338d44f4a0d1db02850413c32024-12-16T22:53:47ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532024-12-0135110.1080/09546634.2024.2355256Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta-analysisJiaxing Chen0Dongyun Lei1Peng Cao2Junchen He3Litao Zhang4Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, ChinaDepartment of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, ChinaDepartment of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, ChinaDepartment of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, ChinaDepartment of Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, ChinaBackground and objective Brivudine has been used in herpes zoster (HZ) treatment for years, but the safety and efficacy of brivudine are inconclusive. Here we perform a meta-analysis to assess the efficacy, safety, incidence of postherpetic neuralgia of brivudine.Methods Data of randomized controlled Trials (RCTS) were obtained from the databases of both English (PubMed, Embase, and Cochrane Library) and Chinese (China National Knowledge Infrastructure, China Science Journal Database, and WanFang Database) literatures from inception to 12 September 2022. Meta-analyses of efficacy and safety of Brivudine for the treatment of herpes zoster for RCTS were conducted.Results The analyses included seven RCTS (2095 patients in experimental group and 2076 patients in control group) in the treatment of HZ with brivudine. It suggested that the brivudine group was superior to the control group in terms of efficacy (p = .0002) and incidence of postherpetic neuralgia (p = .04). But the incidence of adverse reactions has no significant difference between the brivudine and the control groups (p = .22). In addition, subgroup analysis of adverse events also showed that brivudine was about the same safety as other modalities in the treatment of HZ (p > .05).Conclusions Brivudine is effective for HZ. However, the evidence on the safety of brivudine is insufficient.https://www.tandfonline.com/doi/10.1080/09546634.2024.2355256Brivudineherpes zosteracyclovirvalaciclovirpostherpetic neuralgiameta-analysis
spellingShingle Jiaxing Chen
Dongyun Lei
Peng Cao
Junchen He
Litao Zhang
Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta-analysis
Journal of Dermatological Treatment
Brivudine
herpes zoster
acyclovir
valaciclovir
postherpetic neuralgia
meta-analysis
title Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta-analysis
title_full Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta-analysis
title_fullStr Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta-analysis
title_full_unstemmed Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta-analysis
title_short Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta-analysis
title_sort efficacy and safety of brivudine for the treatment of herpes zoster a systematic review and meta analysis
topic Brivudine
herpes zoster
acyclovir
valaciclovir
postherpetic neuralgia
meta-analysis
url https://www.tandfonline.com/doi/10.1080/09546634.2024.2355256
work_keys_str_mv AT jiaxingchen efficacyandsafetyofbrivudineforthetreatmentofherpeszosterasystematicreviewandmetaanalysis
AT dongyunlei efficacyandsafetyofbrivudineforthetreatmentofherpeszosterasystematicreviewandmetaanalysis
AT pengcao efficacyandsafetyofbrivudineforthetreatmentofherpeszosterasystematicreviewandmetaanalysis
AT junchenhe efficacyandsafetyofbrivudineforthetreatmentofherpeszosterasystematicreviewandmetaanalysis
AT litaozhang efficacyandsafetyofbrivudineforthetreatmentofherpeszosterasystematicreviewandmetaanalysis